FDA Device Intelligence
Home › ADMEDUS REGEN PTY LTD › VascuCel 3D

VascuCel 3D

ADMEDUS REGEN PTY LTD · Model UV1206T · UDI-DI 09348992000341

PSQ Prescription
1
510(k) clearances
55
Adverse events (1 deaths)
2
Recalls
22
Facilities

Description

VascuCel™ is prepared from bovine pericardium using the ADAPT® Tissue Processing Technology. The pericardium is procured from cattle originating in Australia. Australia is considered as being of negligible risk for BSE. The device is a sterile, off-white, moist, pre-cut, sheet of acellular collagen, presented sterile in a solution of propylene glycol and sealed in a jar impermeable to air and moisture.

Recalls

DateFirmReason
2023-12-06Baxter Healthcare CorporationCardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the produ
2023-12-06Baxter Healthcare CorporationCardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the produ

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.